Tenstorrent와 Movellus, 차세대 칩렛 기반의 AI 및 HPC 솔루션 발전 위한 전략적 파트너십 체결
September 09, 2024 22:29 ET
|
Movellus
양사 협력 통해 전력 및 성능 최적화를 위한 크로스 파운드리 IP 활성화 전망 서니베일, 캘리포니아, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus와 Tenstorrent가 전략적 제휴의 일환으로 Tenstorrent의 AI 및 HPC 칩렛 솔루션 부문에 Movellus의 디지털 IP 제품군 사용이 가능한 라이선스를...
Interfield Global Software Inc. Provides Update Regarding Its Definitive License Agreement With JRL Energy Inc.
September 09, 2024 17:00 ET
|
Interfield Global Software Inc.
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. ...
Tenstorrent and Movellus Form Strategic Engagement for Next-Generation Chiplet-Based AI and HPC Solutions
September 09, 2024 09:00 ET
|
Movellus
Movellus and Tenstorrent announced that Tenstorrent has licensed Movellus’ digital IP family as part of a strategic engagement, for its AI and HPC chiplets
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
September 09, 2024 08:30 ET
|
Femasys Inc.
ATLANTA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
September 04, 2024 07:30 ET
|
iRhythm
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
Psyence Biomed Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin to be Evaluated as a Potential Treatment for Alcohol Use Disorder (AUD) and Other Substance Use Disorders (SUDs)
September 04, 2024 07:30 ET
|
Psyence Biomedical Ltd.
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM, PBMWW) (“Psyence Biomed” or the “Company”) today announced that the Company has entered into a worldwide, exclusive...
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
September 03, 2024 21:00 ET
|
Shanghai EpimAb Biotherapeutics Co., Ltd.
SHANGHAI and SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, Inc. (“EpimAb” or “EpimAb Biotherapeutics”) a clinical stage biopharmaceutical company specializing in the...
LanzaTech Signs Master License Agreement with SEKISUI to Develop Multiple Commercial Scale Waste-to-Ethanol Plants Across Japan
September 03, 2024 06:00 ET
|
LanzaTech Inc.
LanzaTech progresses partnership with SEKISUI by formalizing commercial framework to construct facilities which significantly advance how municipalities...
Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions
August 29, 2024 18:53 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
Finwave Semiconductor and GlobalFoundries Partner on RF GaN-on-Si Technology for Cellular Handset Applications
August 29, 2024 10:00 ET
|
Finwave Semiconductor
Finwave Semiconductor and GlobalFoundries partner on RF GaN-on-Si technology for cellular handset applications